ASH 2017

Interviews and expert commentary tagged “ASH 2017” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Venetoclax Pro-Apoptotic Therapy Benefits Older Patients with Acute Myeloid Leukemia
Audio Journal of Oncology

Venetoclax Pro-Apoptotic Therapy Benefits Older Patients with Acute Myeloid Leukemia

ATLANTA—Adding anti-BCL-2 therapy with the small-molecule drug venetoclax (VEN) to standard low-dose cytarabine (LDAC) chemotherapy tripled response rates over historical comparators and extended surv

19 January 2018
5:00